本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Intercept Pharmaceuticals

19.00
+0.0000
成交量:- -
成交额:7,530.95万
市值:7.95亿
市盈率:-12.84
高:19.00
开:19.00
低:19.00
收:19.00
数据加载中...
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/09

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/11/09

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/11/09

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/11/09

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/11/08

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2023/11/08

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/11/08

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/11/08

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/11/08

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/11/08

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/10

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/09/26

重要事件披露

Form 8-K - Current report
2023/08/02

重要事件披露

Form 8-K - Current report
2023/08/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/10

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/06/23

重要事件披露

Form 8-K - Current report
2023/06/23

重要事件披露

Form 8-K - Current report
2023/05/25

重要事件披露

Form 8-K - Current report